HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection

Title
HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
Authors
Keywords
Experimental autoimmune encephalomyelitis (EAE), Multiple sclerosis (MS), DRα1-mMOG-35-55 therapy, M2 macrophages, Neuroprotection
Journal
Journal of Neuroinflammation
Volume 12, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-23
DOI
10.1186/s12974-015-0342-4

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started